(20 ILCS 4128/1) (Section scheduled to be repealed on January 1, 2026) Sec. 1. Short title. This Act may be cited as the Alternative Protein Innovation Task Force Act. (Source: P.A. 103-543, eff. 8-11-23 .) |
(20 ILCS 4128/5) (Section scheduled to be repealed on January 1, 2026) Sec. 5. Definitions. As used in this Act: "Alternative proteins" means proteins created from plant-based, fermented, cell-cultured inputs and processes to create foods that share sensory characteristics with conventional meat and dairy. "Cultivated meat" means meat that is produced in a bioreactor from animal cells using a cell cultivation process. "Fermented protein" means a protein that is made from traditional fermentation, biomass fermentation, or precision fermentation. "Plant-based protein" means a protein that is produced directly from a plant. (Source: P.A. 103-543, eff. 8-11-23 .) |
(20 ILCS 4128/10) (Section scheduled to be repealed on January 1, 2026) Sec. 10. Alternative Protein Innovation Task Force. The Alternative Protein Innovation Task Force is established for the purposes of investigating and studying alternative proteins to identify and evaluate possible opportunities that the protein innovation and the alternative protein industry offer in the State. The Task Force shall study and draft a report on how the State may best support the growing alternative protein industry in the State. The Task Force shall: (i) examine the potential economic development benefits and job creation potential of the plant-based protein, cultivated meat, and fermented protein industries in the State; (ii) identify the environmental impacts of alternative proteins and their supply chains; (iii) examine if alternative proteins can strengthen the State's food resilience; (iv) assess how alternative proteins may affect individual health, public health, and food security in the State; and (v) identify ways the State may foster the growth of the emerging alternative protein industry, including by reviewing past and present efforts made to support the broader biotech and life science industries. (Source: P.A. 103-543, eff. 8-11-23 .) |
(20 ILCS 4128/15) (Section scheduled to be repealed on January 1, 2026) Sec. 15. Membership; appointments; meeting. (a) The Alternative Protein Innovation Task Force shall consist of the following members: (1) one member of the Senate, who shall be appointed | ||
| ||
(2) one member of the Senate, who shall be appointed | ||
| ||
(3) one member of the House of Representatives, who | ||
| ||
(4) one member of the House of Representatives, who | ||
| ||
(5) the Director of Commerce and Economic Opportunity | ||
| ||
(6) the Director of Agriculture or the Director's | ||
| ||
(7) 5 members who are appointed by the Director of | ||
| ||
(8) 6 members who are appointed by the Governor. Of | ||
| ||
(b) Members of the Task Force shall not receive compensation for their services to the Task Force. (c) All appointments shall be made not later than 30 days after the effective date of this Act. (d) The co-chairs of the Task Force shall schedule no fewer than 4 meetings of the Task Force, including not less than one public hearing. The co-chairs shall convene the first meeting of the Task Force within 60 days after the effective date of this Act. (e) The Department of Agriculture shall provide administrative and other support to the Task Force. (Source: P.A. 103-543, eff. 8-11-23; 103-564, eff. 11-17-23 .) |
(20 ILCS 4128/20) (Section scheduled to be repealed on January 1, 2026) Sec. 20. Report; dissolution of Task Force; repeal of Act. (a) The Task Force shall submit a report of its findings and recommendations to the General Assembly no later than June 30, 2025. (b) The Task Force shall be dissolved on December 31, 2025. (c) This Act is repealed on January 1, 2026. (Source: P.A. 103-543, eff. 8-11-23; 103-564, eff. 11-17-23; 103-811, eff. 8-9-24.) |
(20 ILCS 4128/99) (Section scheduled to be repealed on January 1, 2026) Sec. 99. Effective date. This Act takes effect upon becoming law. (Source: P.A. 103-543, eff. 8-11-23 .) |